Compare OKTA & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OKTA | COO |
|---|---|---|
| Founded | 2009 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Ophthalmic Goods |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.0B | 15.9B |
| IPO Year | 2017 | N/A |
| Metric | OKTA | COO |
|---|---|---|
| Price | $85.31 | $81.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 37 | 11 |
| Target Price | ★ $116.86 | $89.64 |
| AVG Volume (30 Days) | ★ 2.6M | 1.9M |
| Earning Date | 03-04-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.08 | ★ 1.87 |
| Revenue | $2,840,000,000.00 | ★ $4,092,400,000.00 |
| Revenue This Year | $13.64 | $6.61 |
| Revenue Next Year | $9.10 | $5.36 |
| P/E Ratio | $78.98 | ★ $43.69 |
| Revenue Growth | ★ 12.12 | 5.06 |
| 52 Week Low | $75.05 | $61.78 |
| 52 Week High | $127.57 | $94.17 |
| Indicator | OKTA | COO |
|---|---|---|
| Relative Strength Index (RSI) | 45.27 | 53.60 |
| Support Level | $83.36 | $80.51 |
| Resistance Level | $89.79 | $83.24 |
| Average True Range (ATR) | 3.57 | 1.76 |
| MACD | -0.13 | 0.11 |
| Stochastic Oscillator | 44.09 | 77.30 |
Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.